Bayonet Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ambattur, Tamil Nadu, India, established in 2014.
2014 Ambattur, Tamil Nadu, India Active
Last Updated:
Access Report
About Bayonet Pharmaceuticals Private Limited

Bayonet Pharmaceuticals Private Limited, a active private limited company, was established on 24 February 2014 in Ambattur, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100TN2014PTC095154. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Girisan Karankara (Whole-Time Director), Mahesh Velayudhan Geetha (Whole-Time Director), Deepak Narayanan Nair (Whole-Time Director). Past directors included Girisan Karankara, Mahesh Velayudhan Geetha, Deepak Narayanan Nair. It holds no open charges and ₹2.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No.F1, Arvind Manoor,Plot No. 16F Ganga Street, Jothi Nagar,Thirumullaivoy, Al, Ambattur, Tamil Nadu, 600053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TN2014PTC095154

  • Registration Number

    095154

  • Incorporation Date

    24 February 2014

  • Authorized Capital

    ₹4.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 12 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 2.00 M
  • Revenue Growth **** 39.34%
  • Profit Growth **** 190.80%
  • Ebitda **** 269.92%
  • Net Worth 31.71%
  • Total Assets **** 0.84%
Company report

Bayonet Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Bayonet Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bayonet Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Girisan Karankara Whole-Time Director 24 Feb 2014 Current
Mahesh Velayudhan Geetha Whole-Time Director 24 Feb 2014 Current
Deepak Narayanan Nair Whole-Time Director 24 Feb 2014 Current
Manoharan Managing Director 24 Feb 2014 Current
Anosh Chandran Whole-Time Director 04 Jan 2019 Current
Maju Gopinathan Whole-Time Director 04 Jan 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Sep 2019 Past
Pramod Abcsdd Director 03 Sep 2019 Past
Pramod Abcsdd Director 03 Sep 2019 Past
Pramod Abcsdd Director 31 Mar 2016 Past
Pramod Abcsdd Additional Director 03 Sep 2019 Past
Pramod Abcsdd Additional Director 03 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bayonet Pharmaceuticals.

Bayonet Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.34% increase. The company also saw a substantial improvement in profitability, with a 190.8% increase in profit. The company's net worth Soared by an impressive increase of 31.71%.

Bayonet Pharmaceuticals revenue growth over time
Bayonet Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 39.34%
*******
*******
*******
*******
Revenue from Operations
*******
 39.34%
*******
*******
*******
*******
Total Assets
*******
 0.84%
*******
*******
*******
*******
Profit or Loss
*******
 190.80%
*******
*******
*******
*******
Net Worth
*******
 31.71%
*******
*******
*******
*******
EBITDA
*******
 269.92%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bayonet Pharmaceuticals?

In 2023, Bayonet Pharmaceuticals had a public holding of 33.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹2,000,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of Travancore : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
13 Jan 2016 State Bank Of Travancore ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Bayonet Pharmaceuticals?

Unlock and access historical data on people associated with Bayonet Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bayonet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bayonet Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bayonet Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Bayonet Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Bayonet Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Charges

    The activity A charge registered on 13 Jan 2016 via Charge ID 10618615 with State Bank Of Travancore was fully satisfied on 26 Jun 2024. was completed.

  • Director Appointment

    Anosh Chandran was appointed as a Whole-time director was appointed as a Whole-time director on 04 Jan 2019 & has been associated with this company since 7 years 4 months . was recorded as a recent event.

  • Director Appointment

    Maju Gopinathan was appointed as a Whole-time director was appointed as a Whole-time director on 04 Jan 2019 & has been associated with this company since 7 years 4 months . was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of Travancore amounted to Rs. 2.00 M with Charge ID 10618615 was registered on 13 Jan 2016. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bayonet Pharmaceuticals Private Limited?

The CIN of Bayonet Pharmaceuticals Private Limited is U24100TN2014PTC095154.

Where is Bayonet Pharmaceuticals Private Limited headquartered?

Bayonet Pharmaceuticals Private Limited is headquartered at Flat No.F1, Arvind Manoor,Plot No. 16F Ganga Street, Jothi Nagar,Thirumullaivoy, Al, Ambattur, Tamil Nadu, 600053.

When was Bayonet Pharmaceuticals Private Limited incorporated?

Bayonet Pharmaceuticals Private Limited was incorporated on 24 February 2014.

Who are the current directors of Bayonet Pharmaceuticals Private Limited?

The current directors of Bayonet Pharmaceuticals Private Limited are

What is the primary industry of Bayonet Pharmaceuticals Private Limited?

The primary industry of Bayonet Pharmaceuticals Private Limited is Trade.

Is Bayonet Pharmaceuticals Private Limited a listed company?

Bayonet Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Bayonet Pharmaceuticals Private Limited?

The authorized capital of Bayonet Pharmaceuticals Private Limited is ₹4.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Bayonet Pharmaceuticals Private Limited?

The compliance status of Bayonet Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available